skip to Main Content

Sign up for our Free Daily Digest newsletter: Actionable insight every morning, designed for the self-directed investor. Find out more

Biotechnology is an emerging field of science that involves the use of living microorganisms to make chemicals, pharmaceuticals and products that are beneficial to humans, perform industrial tasks, or are part of innovative medical treatments.

It is a popular sector for investors and traders because of the ground breaking innovation displayed by the companies involved. While many biotech companies focus on clinical research and the development of new drugs aimed at treating diseases and medical conditions, this industry has a host of different applications.

Biotech companies can offer explosive returns for investors and traders when their products overcome all regulatory hurdles.

The best biotech companies to invest and trade in tend to have several commonalities: strong earnings growth, institutional investment participation, and a solid foundation of rigorous scientific research.

Software company Vantagepoint AI has developed the first artificial intelligence (AI) trading software in the world available to retail investors and traders. Its software now provides predictive trend forecasts into the biotech sector.

“We are thrilled to give traders looking for solid intelligence access to the biotech sector with the power of artificial intelligence. Superior tools can help traders immensely,” said Lane Mendelsohn, President of Vantagepoint AI. “Biotech stocks offer huge trading opportunities; we have been testing this sector against our neural networks for the last several years and the results have been remarkable.”

With trend forecasts that are up to 86% accurate, one to three days in advance, Mendelsohn points out, his team have been able to forecast the individual biotech stocks with a minimum of at least 70% accuracy, which is a threshold to be included in the company’s software.

“Consistently and accurately forecasting the biotech sector now opens up new trading possibilities for traders looking for the edge Vantagepoint’s artificial intelligence offers,” Mendelsohn added.

Artificial intelligence applications are now regularly being used by traders to help them to optimise investments across a range of markets, including equities, foreign exchange and commodities. Financial AI applications have the advantage of being more effective at managing risk than human traders and are also able to process much more data on a day to day basis.

The Armchair Trader says:

Many traders now use AI applications as part of their day to day portfolio management strategy. The level of innovation in the machine learning sector, particularly with reference to active financial markets trading, is impressive. Traders now have the tools at their fingertips that hedge funds and investment banks had access to only a few years ago.

Make sure you sign up to our newsletter for regular updates on financial markets and trading software.

Share this article

Sign up to our Daily Digest newsletter and receive our latest insight every morning

Please note this article does not constitute investment advice. Investors are encouraged to do their own research beforehand or consult a professional advisor.

Stuart Fieldhouse

Stuart Fieldhouse

Stuart Fieldhouse has spent 25 years in journalism and marketing, including as a wealth management editor for the Financial Times group, covering capital markets and international private banking, and as an investment banking correspondent for Euromoney in Hong Kong. He was the founder editor of The Hedge Fund Journal.

Stuart has worked at CMC Markets, supporting the re-launch of its global financial spread betting and CFD trading platforms. He is also the author of two books on trading, published by Financial Times Pearson. Based in The Armchair Trader’s London office, Stuart continues to advise fund managers, private banks, family offices and other financial institutions.

Related articles

This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Back To Top